If you need more lookups,
subscriptions start at $34 USD/month.
Ben Chaffey Location
Manchester, England, GB
Ben Chaffey Work
2025 -now Global Director, CDx Lead @
2022 -2025 Global Director @
2021 -2022 Global Diagnostics Lead @
2018 -2021 Senior Global Product Manager, Oncology and Precision Diagnostics @
2016 -2018 Scientific Business Development Manager @ NewGene Limited.
2011 -2016 Clinical Operations and Business Development Manager @ Biosignatures
2010 -2011 Senior Scientist @ Helena Biosciences
2007 -2010 Research Associate @ HB Innovations
2003 -2006 Post Doctoral Research Associate @
1998 -2000 Software Development and Testing @ Nonlinear Dynamics Ltd
Ben Chaffey Education
Newcastle University
PhD (Involvement of Inflammatory Mediators in Rejection of Organ Transplants)
2000-2003
Ben Chaffey Skills
Precision Medicine
Companion Diagnostics (CDx)
Molecular Oncology
In Vitro Diagnostics (IVD)
Biochemistry
Medical Devices
Molecular Biology
Clinical Trials
Immunology
Assay Development
Chemistry
Clinical Research
Biotechnology
Proteomics
Biomarkers
IVD
Cell Biology
Translational Research
Immunohistochemistry
Drug Discovery
Oncology Clinical Research
Grant Preparation
Personalized Medicine
In Vitro Diagnostics
Big Data
Companion Diagnostics
Stratified Medicine
Operations Management
Strategic Planning
Tactical Planning
Life Sciences
Regulatory Affairs
Food
SQL
Research
Hospitals
Ben Chaffey Summary
Ben Chaffey, based in Manchester, England, GB, is currently a Global Director, CDx Lead at Merck Group. Ben Chaffey brings experience from previous roles at AstraZeneca, QIAGEN and NewGene Limited.. Ben Chaffey holds a 2000 - 2003 PhD in Involvement of Inflammatory Mediators in Rejection of Organ Transplants @ Newcastle University. With a robust skill set that includes Precision Medicine, Companion Diagnostics (CDx), Molecular Oncology, In Vitro Diagnostics (IVD), Biochemistry and more. Ben Chaffey has 1 emails on RocketReach.
Looking for a different Ben Chaffey?
Find contact details for 700 million professionals.